Tranexamic acid for the treatment of postpartum haemorrhage: An international, randomised, double blind, placebo controlled trial. The WOMAN trial showed that if given within 3 hours, TXA can reduce the risk of death due to bleeding by one third
WOMAN-ETAC:Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage
ETAPLaT: Effects of tranexamic acid on platelet function and thrombin generation (ETAPlaT): WOMAN trial sub-study.
WOMAN-PharmacoTXA trial will assess the pharmacokinetics and pharmacodynamics of tranexamic acid administered by intravenous (IV), intramuscular (IM) or oral liquid routes in women giving birth by caesarean section with at least one risk factor for PPH
Are you interested in collaborating on one of our ongoing trials? Email enquiries to email@example.com